Literature DB >> 10835430

Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum.

C Y Liu1, M Schröder, R J Kaufman.   

Abstract

IRE1 and PERK are type I transmembrane serine/threonine protein kinases that are activated by unfolded proteins in the endoplasmic reticulum (ER) to signal adaptive responses. IRE1 is present in all eukaryotic cells and signals the unfolded protein response through its kinase and endoribonuclease activities. PERK signals phosphorylation of a translation initiation factor to inhibit protein synthesis in higher eukaryotic cells but is absent in the Saccharomyces cerevisiae genome. The amino acid sequences of the amino-terminal ER luminal domains (NLDs) from IRE1 and PERK display limited homology and have diverged among species. In this study, we have demonstrated that the NLD of yeast Ire1p is required for signaling. However, the NLDs from human IRE1alpha and murine IRE1beta and the Caenorhabditis elegans IRE1 and PERK function as replacements for the S. cerevisiae Ire1p-NLD to signal the unfolded protein response. Replacement of the Ire1p-NLD with a functional leucine zipper dimerization motif yielded a constitutively active kinase that surprisingly was further activated by ER stress. These results demonstrate that ER stress-induced dimerization of the NLD is sufficient for IRE1 and PERK activation and is conserved through evolution. We propose that ligand-independent activation of IRE1 and PERK permits homodimerization upon accumulation of unfolded proteins in the lumen of the ER.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835430     DOI: 10.1074/jbc.M004454200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  145 in total

Review 1.  Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse.

Authors:  David Ron
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 3.  Translational control in the endoplasmic reticulum stress response.

Authors:  David Ron
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 4.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

Review 5.  The UPR and cell fate at a glance.

Authors:  Philip I Merksamer; Feroz R Papa
Journal:  J Cell Sci       Date:  2010-04-01       Impact factor: 5.285

Review 6.  Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Harikrishna Tanjore; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

Review 7.  Early Events in the Endoplasmic Reticulum Unfolded Protein Response.

Authors:  Steffen Preissler; David Ron
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

8.  PCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways.

Authors:  Xiaohui Xu; Yushang Cui; Lei Cao; Ye Zhang; Yan Yin; Xue Hu
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

9.  Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress.

Authors:  Zhi-Ming Huang; Thomas Tan; Hiderou Yoshida; Kazutoshi Mori; Yanjun Ma; T S Benedict Yen
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  ATF6 signaling is required for efficient West Nile virus replication by promoting cell survival and inhibition of innate immune responses.

Authors:  Rebecca L Ambrose; Jason M Mackenzie
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.